STOCKS NEWS US-U.S. earnings diary for July 2
Stocks on the move [HOT-RTRS]
Real-time Equity news [U][E][RESF/US]
For U.S. stock market report double-click [.N] 1755 ET 01July2009-U.S. earnings diary for July 2 ------------------------------------------------------------------------------
The day's earnings calendar includes quarterly results from Acuity Brands
Inc (AYI.N).
For more please double click [RESF/US]
Reuters Messaging rm://caroline.valetkevitch.reuters.com@reuters.net 1753 ET 01July2009-U.S. economic diary for July 2 ------------------------------------------------------------------------------
The day's economic agenda includes data on monthly employment and factory orders.
For more please double click [ECI/US]
Reuters Messaging rm://caroline.valetkevitch.reuters.com@reuters.net 1633 ET 01July2009-US STOCKS-Wall St rises on recovery hope; jobs data eyed ------------------------------------------------------------------------------
U.S. stocks rose on Wednesday, the start of the third quarter, as reassuring manufacturing data from China, Europe and the United States reinforced hopes that the world's economy is on the road to recovery.
For more please double click [ID:nN01523702]
Reuters Messaging rm://caroline.valetkevitch.reuters.com@reuters.net 1510 ET 01July2009-Gov declares fiscal emergency in California ------------------------------------------------------------------------------
California Gov. Arnold Schwarzenegger declared a fiscal emergency on Wednesday for the government of the most populous U.S. state to force lawmakers into a special session to tackle a $24.3 billion state budget gap. [ID:nN01510100]
Reuters Messaging:rm://Charles.mikolajczak.reuters.com@reuters.net 1426 ET 01July2009-OPEC unlikely to hike output in Sept-Kuwait ------------------------------------------------------------------------------
OPEC is unlikely to raise oil output when its ministers meet in September as the oil market is still oversupplied, Kuwait's oil minister said on Wednesday.
"I doubt there will be a further increase in production," Sheikh Ahmad al-Abdullah al-Sabah told reporters at parliament when asked for comment about similar views by fellow OPEC members about the September meeting.
The minister said demand was still less than supply.
For details, see [ID:nL1593318]
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 1325 ET 01July2009-Immersion to start probe, shares sink ------------------------------------------------------------------------------
Shares of Immersion Corp (IMMR.O) tumbled on Wednesday after the company
said it was conducting an internal investigation into certain previous revenue
transactions in its medical business.
"As a result of this investigation, Immersion may discover information that could raise issues with respect to its previously-reported financial information, which could be material," the company said.
For details, see [ID:nBNG520039]
The stock dropped 22 percent to $3.86.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 1321 ET 01July2009-Ford sales drop 10.9 pct in June ------------------------------------------------------------------------------
Ford Motor Co (F.N) said on Wednesday that U.S. sales fell 10.9 percent in
June for all of its brands, at the top of its expectations.
The automaker had expected to post a sales decline in the 10 to 20 percent range in June. It also expects U.S. auto industry sales to be down in the 25 to 30 percent range.
For details, see [ID:nN01510786]
Shares of Ford rose 0.7 percent to $6.11.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 1312 01July2009-Traders become bullish on Elan, calls heat up ------------------------------------------------------------------------------
Option traders have turned optimistic on Elan Corp (ELN.I) (ELN.N) after the Irish drugmaker said it will benefit from the Biogen-Acorda deal. Elan shares jumped 7.85 percent to $6.87. Players in the July and August contracts were seen scooping up calls expecting continued bullish movement in the stock, said Andrew Wilkinson, analyst at Interactive Brokers Group. The July $7 strike had 1,000 calls bought for an average 40-cent premium and 10,000 calls were picked up at the Aug $7 strike for about 75 cents. Elan said it is set to receive 7 percent of the upfront and milestone payments allocated to Acorda Therapeutics by Biogen Idec for its role in manufacturing experimental multiple sclerosis drug, Fampridine-SR. The Sunday Times newspaper this week said Swiss drugmaker Novartis is in talks to buy parts of Elan. Elan, which hired Citigroup in January to conduct a review of the business, said on June 10 it expected to conclude a strategic transaction "in the near term", after talking over the past few months with a number of the global players in pharmaceuticals and biotechnology.
Reuters Messaging: doris.frankel.reuters.com@reuters.net
© Thomson Reuters 2009 All rights reserved.

UK
US